4
Changes in Ownership
CUMBERLAND PHARMACEUTICALS INC Filed Acc 0001209191-22-040113
SVP and Chief Development Off. disposed of 33,500 shares (other)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pavliv Leo SVP and Chief Development Off. | 2022-05-31 | Other disposition | −33,500 | $2.09 | $70,015 | 129,618 | D |
| Derivatives | |||||||
| Pavliv Leo SVP and Chief Development Off. | 2021-03-17 | Returned to the company · Options (right to buy) | −5,000 | 0 | D | ||
| Pavliv Leo SVP and Chief Development Off. | 2022-03-16 | Returned to the company · Options (right to buy) | −5,000 | 0 | D | ||
Loading xslF345X03/doc4.xml…